Digestive Diseases and Sciences

, Volume 56, Issue 10, pp 2810–2817 | Cite as

The Protective Effect of the Recombinant 53-kDa Protein of Trichinella spiralis on Experimental Colitis in Mice

  • Linlin Du
  • Hao Tang
  • Zhongfu Ma
  • Jia Xu
  • Wenchao Gao
  • Jiajia Chen
  • Wenjia Gan
  • Zhaoping Zhang
  • Xinbing Yu
  • Xingwang Zhou
  • Xuchu Hu
Original Article



Helminth infection has been proven to reduce the severity of experimental inflammatory bowel disease (IBD). The excretory-secretory proteins of helminths play an important role in the process of immunomodulation.


In the present study, we aimed to investigate the protective potential of recombinant Trichinella spiralis (TS) 53-kDa protein (rTsP53), a component of excretory-secretory proteins, on experimental colitis in mice.


BALB/c mice were treated subcutaneously with 50 μg rTsP53 three times at an interval of 5 days. Colitis was induced by intrarectal administration of 5 mg trinitrobenzene sulfonic acid (TNBS). Disease activities and macroscopic and microscopic scores were evaluated. To determine immune response provoked by rTsP53, we measured specific IgG1 and IgG2a values against rTsP53 in sera of mice. We also detected cytokine profiles as well as the markers of alternatively activated macrophages (M2) in mice.


RTsP53 ameliorated significantly the disease activity index (DAI) as well as the macroscopic and microscopic scores. IgG1 but not IgG2a was the predominant specific antibody detected in the sera of immunized mice, indicating the potential of stimulating T-helper (Th) 2 bias response by rTsP3. Pre-treatment with rTsP53 decreased serum Th1 cytokines (TNF-a, IFN-γ) and elevated serum levels of serum Th2 cytokines (IL-4, IL-13); it also decreased colonic Th1 cytokines (TNF-α, IL-6) and colonic regulatory cytokines (IL-10, TGF-β1). RTsP53 increased colonic M2 markers, arginase-1 (Arg-1), and found in inflammatory zone 1 (FIZZ1), compared to mice without rTsP53 pretreatment.


RTsP53 is a potential protective agent for IBD.


Inflammatory bowel disease 53-kDa protein Trichinella spiralis Alternatively activated macrophages Th2 



This work was supported by the China National Great Basic Research Program (the 973 program, No. 2010CB530003) and the China National Natural Science Foundation (No. 30771887).


  1. 1.
    Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429.PubMedCrossRefGoogle Scholar
  2. 2.
    Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci. 1994;39:555–560.PubMedCrossRefGoogle Scholar
  3. 3.
    Elliott DE, Urban JF Jr, Argo CK, Weinstock JV. Does the failure to acquire helminthic parasites predispose to Crohn’s disease? FASEB J. 2000;14:1848–1855.PubMedCrossRefGoogle Scholar
  4. 4.
    Fox JG, Beck P, Dangler CA, et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat Med. 2000;6:536–542.PubMedCrossRefGoogle Scholar
  5. 5.
    Khan WI, Blennerhasset PA, Varghese AK, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun. 2002;70:5931–5937.PubMedCrossRefGoogle Scholar
  6. 6.
    Elliott DE, Li J, Blum A, et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2003;284:G385–G391.PubMedGoogle Scholar
  7. 7.
    Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis therapy in Crohn’s disease. Gut. 2005;54:87–90.PubMedCrossRefGoogle Scholar
  8. 8.
    Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005;128:825–832.PubMedCrossRefGoogle Scholar
  9. 9.
    Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials. 2009;30:1482–1491.PubMedCrossRefGoogle Scholar
  10. 10.
    Khan WI, Collins SM. Immune-mediated alteration in gut physiology and its role in host defence in nematode infection. Parasite Immunol. 2004;26:319–326.PubMedCrossRefGoogle Scholar
  11. 11.
    Ruyssers NE, De Winter BY, De Man JG, et al. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis. 2009;15:491–500.PubMedCrossRefGoogle Scholar
  12. 12.
    Motomura Y, Wang H, Deng Y, El-Sharkawy RT, Verdu EF, Khan WI. Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Clin Exp Immunol. 2009;155:88–95.PubMedCrossRefGoogle Scholar
  13. 13.
    Yera H, Andiva S, Perret C, Limonne D, Boireau P, Dupouy-Camet J. Development and evaluation of a Western blot kit for diagnosis of human trichinellosis. Clin Diagn Lab Immunol. 2003;10:793–796.PubMedGoogle Scholar
  14. 14.
    Smith P, Mangan NE, Walsh CM, et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol. 2007;178:4557–4566.PubMedGoogle Scholar
  15. 15.
    Wendelsdorf K, Bassaganya-Riera J, Hontecillas R, Eubank S. Model of colonic inflammation: immune modulatory mechanisms in inflammatory bowel disease. J Theor Biol. 2010;264:1225–1239.PubMedCrossRefGoogle Scholar
  16. 16.
    Nagano I, Wu Z, Takahashi Y. Species-specific antibody responses to the recombinant 53-kilodalton excretory and secretory proteins in mice infected with Trichinella spp. Clin Vaccine Immunol. 2008;15:468–473.PubMedCrossRefGoogle Scholar
  17. 17.
    Bobin-Dubigeon C, Collin X, Grimaud N, Robert JM, Le Baut G, Petit JY. Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis. Eur J Pharmacol. 2001;431:103–110.PubMedCrossRefGoogle Scholar
  18. 18.
    Hunter MM, Wang A, Hirota CL, McKay DM. Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol. 2005;174:7368–7375.PubMedGoogle Scholar
  19. 19.
    Stewart GL, Wood BG, Boley RB. Modulation of host response by Trichinella pseudospiralis. Parasite Immunol. 1985;7:223–233.PubMedCrossRefGoogle Scholar
  20. 20.
    Chakir H, Wang H, Lefebvre D, Webb J, Scott FW. T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3. J Immunol Methods. 2003;278:157–169.PubMedCrossRefGoogle Scholar
  21. 21.
    Rengarajan J, Szabo S, Glimcher L. Transcriptional regulation of Th1/Th2 polarization. Immunol Today. 2000;21:479–483.PubMedCrossRefGoogle Scholar
  22. 22.
    Deventer SJH. Tumor necrosis factor and Crohn’s disease. Gut. 1997;40:443–448.PubMedGoogle Scholar
  23. 23.
    Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr, Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol. 2004;34:2690–2698.PubMedCrossRefGoogle Scholar
  24. 24.
    Zurawski G, De Vries JE. Interleukin-13, an interleukin-4 like cytokine that acts on monocytes and B cells, but not on T-cells. Immunol Today. 1994;15:19–26.PubMedCrossRefGoogle Scholar
  25. 25.
    Herbert DR, Hölscher C, Mohrs M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 2004;20:623–635.PubMedCrossRefGoogle Scholar
  26. 26.
    Persaud R, Wang A, Reardon C, McKay DM. Characterization of the immuno-regulatory response to the tapeworm Hymenolepis diminuta in the non-permissive mouse host. Int J Parasitol. 2007;37:393–403.PubMedCrossRefGoogle Scholar
  27. 27.
    Hunter MM, Wang A, Parhar KS, et al. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology. 2010;138:1395–1405.PubMedCrossRefGoogle Scholar
  28. 28.
    Witte MB, Barbul A. Arginine physiology and its implication for wound healing. Wound Repair Regen. 2003;11:419–423.PubMedCrossRefGoogle Scholar
  29. 29.
    Anthony RM, Urban JF, Alem F, et al. Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med. 2006;12:955–960.PubMedCrossRefGoogle Scholar
  30. 30.
    Loke P, Gallagher I, Nair MG, et al. Alternative activation is an innate response to injury that requires CD4 + T cells to be sustained during chronic infection. J Immunol. 2007;179:3926–3936.PubMedGoogle Scholar
  31. 31.
    Goodridge HS, Marshall FA, Else KJ, et al. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J Immunol. 2005;174:284–293.PubMedGoogle Scholar
  32. 32.
    Kane CM, Cervi L, Sun J, et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol. 2004;173:7454–7461.PubMedGoogle Scholar
  33. 33.
    Hunter MM, Wang A, McKay DM. Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology. 2007;132:1320–1330.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Linlin Du
    • 1
  • Hao Tang
    • 1
  • Zhongfu Ma
    • 1
  • Jia Xu
    • 1
  • Wenchao Gao
    • 2
  • Jiajia Chen
    • 2
  • Wenjia Gan
    • 2
  • Zhaoping Zhang
    • 2
  • Xinbing Yu
    • 2
  • Xingwang Zhou
    • 3
  • Xuchu Hu
    • 2
    • 4
  1. 1.Department of General Internal Medicine, The First Affiliated HospitalSun Yat-sen UniversityGuangzhouChina
  2. 2.Department of Parasitology, Zhongshan School of MedicineSun Yat-sen UniversityGuangzhouChina
  3. 3.Department of Biochemistry, Zhongshan School of MedicineSun Yat-sen UniversityGuangzhouChina
  4. 4.GuangzhouChina

Personalised recommendations